Coloplast shares slide to nearly bottom of STOXX after Q1 miss

Coloplast A/S

06/02/2026 08:57

** Shares in Coloplast COLOb.CO fall 8% to their lowest since March 2018 after the Danish medical equipment maker reported lower-than-expected Q1 results

** Its operating profit (EBIT) came at 1.82 billion Danish crowns ($287.39 million), below the LSEG-polled analyst estimate of 1.95 billion

** The group's EBIT margin reached 26% in the quarter, below the expectation of 27.1% seen in a consensus cited by Jyske Bank

** Jefferies says the miss on margin was due to negative foreign exchange effects and problems in the group's wound care brand Kerecis, which was affected by regulatory changes volatility

** Sydbank notes the group has started the financial year on a subdued note with growth dampened by weaker consumer sentiment in China and product recalls of bandages

** The group maintained its overall guidance, but expectations for Kerecis have been lowered to 10% vs. previously around 25%

** The shares, on track for their worst day since 2017, are among weakest performers on STOXX .STOXX

($1 = 6.3329 Danish crowns)

 (Reporting by Vera Dvorakova)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))